Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention—MACUSTAR

BACKGROUND: There is an unmet need for treatment options in intermediate age-related macular degeneration (iAMD). However, for any new interventions to be tested in clinical trials, novel currently unavailable clinical endpoints need to be developed. Thus, the MACUSTAR study aims to develop and eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Terheyden, Jan H., Holz, Frank G., Schmitz-Valckenberg, Steffen, Lüning, Anna, Schmid, Matthias, Rubin, Gary S., Dunbar, Hannah, Tufail, Adnan, Crabb, David P., Binns, Alison, Sánchez, Clara I., Hoyng, Carel, Margaron, Philippe, Zakaria, Nadia, Durbin, Mary, Luhmann, Ulrich, Zamiri, Parisa, Cunha-Vaz, José, Martinho, Cecília, Leal, Sergio, Finger, Robert P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368769/
https://www.ncbi.nlm.nih.gov/pubmed/32682441
http://dx.doi.org/10.1186/s13063-020-04595-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368769/
https://www.ncbi.nlm.nih.gov/pubmed/32682441
http://dx.doi.org/10.1186/s13063-020-04595-6

Ejemplares similares